Skip to main content

Table 12 Use of macrolides according to habitual treatment

From: Inadequate use of antibiotics in the covid-19 era: effectiveness of antibiotic therapy

 

Total (n = 13,932)

No. (%)

With macrolides n = 8382 (%)

Without macrolides n = 5502 (%)

p value

Highly active antiretroviral therapy (HAART)

13,853

93 (0.7)

57 (0.7)

36 (0.7)

0.86

Metformin

13,860

1890 (13.6)

1154 (13.8)

736 (13.4)

0.51

Systemic corticosteroids

13,849

591 (4.3)

332 (4.0)

259 (4.7)

0.033

Inhaled corticosteroids

13,808

1304 (9.4)

796 (9.6)

508 (9.3)

0.61

Hydroxychloroquine

13,855

70 (0.5)

51 (0.6)

19 (0.4)

0.033

Rapamycin (sirolimus)

13,820

63 (0.5)

41 (0.5)

22 (0.4)

0.44

Immunosuppressants

13,836

486 (3.5)

278 (3.3)

208 (3.8)

0.14

Biological therapy (monoclonal antibodies)

13,851

180 (1.3)

93 (1.1)

87 (1.6)

0.016